Inside Investor Relations


M&A focus: Tech and pharmaceutical takeovers on the rise

Comments (0) | 1 Jul 2009 | RatingRating (-1 to +1): 0.0 | Print

Technology and pharmaceutical takeovers are leading the way, but expect hostile activity elsewhere in the wake of Madoff and AIG scandals.


Technology and pharmaceutical firms have led the way this year in high-profile merger and acquisition activity, from Oracle-Sun Microsystems and Roche-Genentech to Pfizer-Wyeth and Merck-Schering-Plough.

In the last few months, we’ve also seen plays in other industries with DirecTV’s tie-up with Liberty Entertainment and Pepsi’s plans to ...

Register now to read the rest of this article! Registration is free and you will be able to read five articles every month.

Become a subscriber for unlimited access.

Read More About Topics

Featured Articles

Print magazine
All the articles from the May edition of
IR magazine
More

Technology
Walmart launches a new IR app plus
a video-heavy annual report
More

IR societies
How the Netherlands’ IR association
has promoted IR for 20 years
More